Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microfibril-associated glycoprotein 3 (MFAP3) is a protein encoded by the MFAP3 gene, which forms part of the extracellular matrix and is associated with elastin-containing microfibrils[3][4]. It contains a single immunoglobulin-like (Ig-like) C2 domain[1][3]. MFAP3 is considered a structural protein contributing to microfibril assembly, elastin fiber formation, and maintenance of tissue homeostasis in connective tissues[1][2][3]. MFAP3 is more ubiquitously expressed than some other family members, suggesting broader functional roles across tissues[2][4]. While microfibrillar-associated proteins as a family are implicated in skeletal, metabolic, and potentially cancer-related disorders, MFAP3 has not been specifically identified as a direct therapeutic target or as interacting with any approved drugs[2][4]. One of its important paralogs is MFAP3L[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microfibril-associated glycoprotein 3 (MFAP3).